CPHI Experts Report that Small to Mid-sized US CDMOs Must Invest Now to Benefit from 2025 Contract Funding Surge
PharmaTech
APRIL 30, 2024
Key areas to invest include manufacturing process improvements, quality management, and AI.
64 
9th Advanced GMP Workshop 2024 was organised by IPA
Express Pharma
OCTOBER 27, 2024
It is encouraging to see that the Indian pharmaceutical sector is making significant strides towards becoming a global benchmark for quality through capability building, process improvements, talent development, digitalisation, and fostering a quality-first mindset.”
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Genentech to open new high-tech biologics facility
European Pharmaceutical Review
FEBRUARY 15, 2023
When operational in early 2025, the new facility will be the first commercial biopharma manufacturing facility to incorporate the latest manufacturing technologies along with in-house process improvements for increased flexibility, speed and output under one roof.
The next frontier: Global leadership in biopharma
Express Pharma
JULY 10, 2024
With advancements in biotechnology, robust scientific capabilities, cost-effective manufacturing processes, a large workforce and a shift towards more complex biologic drugs, India is at the cusp of a huge opportunity to emerge as a leader in biopharma. On a monthly basis, this market adds around $1.16
Let's personalize your content